Outcome of Patients Treated With ECLS
Sponsor
Nanjing Medical University (Other)
Overall Status
Recruiting
CT.gov ID
NCT04405817
Collaborator
(none)
300
1
168
1.8
Study Details
Study Description
Brief Summary
Extracorporeal life support (ECLS), also called extracorporeal membrane oxygenation (ECMO), is an extracorporeal technique of providing effective circulatory and (or) respiratory failure, with a growing number of critically ill patients benefit from it. The aim of this study is to investigate the outcome of patients treated With ECMO, and to evaluate the short-term and long-term outcomes of patients with ECLS.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Study Design
Study Type:
Observational
Anticipated Enrollment
:
300 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Outcome of Patients Treated With Extracorporeal Life Support
Actual Study Start Date
:
Jan 1, 2012
Anticipated Primary Completion Date
:
Dec 31, 2025
Anticipated Study Completion Date
:
Dec 31, 2025
Outcome Measures
Primary Outcome Measures
- Composite of death from any cause, resuscitated circulatory arrest, and implantation of another mechanical circulatory support device [30 days after ECMO implantation]
Secondary Outcome Measures
- All-cause mortality [30 days after ECMO implantation]
- All-cause mortality [12 months after ECMO implantation]
Eligibility Criteria
Criteria
Ages Eligible for Study:
1 Year
to 100 Years
Sexes Eligible for Study:
All
Inclusion Criteria:
- Patients receiving ECMO for circulatory and/or respiratory support
Exclusion Criteria:
- Refusal of consent
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | The first affiliated hospital of nanjing medical university | Nanjing | Jiangsu | China | 210029 |
Sponsors and Collaborators
- Nanjing Medical University
Investigators
- Study Director: Yong-feng Shao, The First Affiliated Hospital with Nanjing Medical University
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Hong Liu,
Investigator of Department of Cardiac Surgery,
Nanjing Medical University
ClinicalTrials.gov Identifier:
NCT04405817
Other Study ID Numbers:
- ECLS-Jsph
First Posted:
May 28, 2020
Last Update Posted:
May 28, 2020
Last Verified:
May 1, 2020
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms: